ImmunoKey

About

ImmunoKey is a Manchester-based research company developing platform technology for CAR T-cell therapy applied to solid cancers.

The company's lead programme targets ovarian cancer, where it aims to deliver durable therapeutic responses to patients with limited existing treatment options.

The company conducts integrated research into immunotherapy and cell therapy development, with a focus on improving survival outcomes and quality of life for cancer patients.

Common questions

Where is ImmunoKey based?

ImmunoKey is based at Manchester, Greater Manchester.

What does ImmunoKey do?

ImmunoKey is a Manchester research company developing CAR T-cell therapy platform technology for solid cancers, with ovarian cancer as its lead indication.

What sector does ImmunoKey work in?

ImmunoKey works in the Research sector.

How can I contact ImmunoKey?

You can contact ImmunoKey by email at gray.kueberuwa@immunokey.co.uk or through its website at https://immunokey.co.uk.